Xanthine oxidase inhibitor tungsten prevents the development of atherosclerosis in ApoE knockout mice fed a Western-type diet

Katrin Schröder, Carmine Vecchione, Oliver Jung, Judith G. Schreiber, Ronit Shiri-Sverdlov, Patrick J. van Gorp, Rudi Busse, Ralf P. Brandes

Research output: Contribution to journalArticle

58 Citations (Scopus)

Abstract

Hyperlipidemia enhances xanthine oxidase (XO) activity. XO is an important source of reactive oxygen species (ROS). Since ROS are thought to promote atherosclerosis, we hypothesized that XO is involved in the development of atherosclerosis. ApoE -/- mice were fed a Western-type (WD) or control diet. In subgroups, tungsten (700 mg/L) was administered to inhibit XO. XO is a secreted enzyme which is formed in the liver as xanthine dehydrogenase (XDH) and binds to the vascular endothelium. High expression of XDH was found in the liver and WD increased liver XDH mRNA and XDH protein expression. WD induced the conversion of XDH to the radical-forming XO. Moreover, WD increased the hepatic expression of CD40, demonstrating activation of hepatic cells. Aortic tissue of ApoE -/- mice fed a WD for 6 months exhibited marked atherosclerosis, attenuated endothelium-dependent relaxation to acetylcholine, increased vascular oxidative stress, and mRNA expression of the chemokine KC. Tungsten treatment had no effect on plasma lipids but lowered the plasma XO activity. In animals fed a control diet, tungsten had no effect on radical formation, endothelial function, or atherosclerosis development. In mice fed a WD, however tungsten attenuated the vascular superoxide anion formation, prevented endothelial dysfunction, and attenuated KC mRNA expression. Most importantly, tungsten treatment largely prevented the development of atherosclerosis in the aorta of ApoE -/- mice on WD. Therefore, tungsten, potentially via the inhibition of XO, prevents the development of endothelial dysfunction and atherosclerosis in ApoE -/- mice on WD.

Original languageEnglish
Pages (from-to)1353-1360
Number of pages8
JournalFree Radical Biology and Medicine
Volume41
Issue number9
DOIs
Publication statusPublished - Nov 1 2006

Fingerprint

Tungsten
Xanthine Oxidase
Apolipoproteins E
Nutrition
Knockout Mice
Xanthine Dehydrogenase
Atherosclerosis
Liver
Messenger RNA
Blood Vessels
Reactive Oxygen Species
Diet
Plasmas
Oxidative stress
Western Diet
Vascular Endothelium
Hyperlipidemias
Chemokines
Superoxides
Acetylcholine

Keywords

  • Atherosclerosis
  • Oxidative stress

ASJC Scopus subject areas

  • Medicine(all)
  • Toxicology
  • Clinical Biochemistry

Cite this

Xanthine oxidase inhibitor tungsten prevents the development of atherosclerosis in ApoE knockout mice fed a Western-type diet. / Schröder, Katrin; Vecchione, Carmine; Jung, Oliver; Schreiber, Judith G.; Shiri-Sverdlov, Ronit; van Gorp, Patrick J.; Busse, Rudi; Brandes, Ralf P.

In: Free Radical Biology and Medicine, Vol. 41, No. 9, 01.11.2006, p. 1353-1360.

Research output: Contribution to journalArticle

Schröder, Katrin ; Vecchione, Carmine ; Jung, Oliver ; Schreiber, Judith G. ; Shiri-Sverdlov, Ronit ; van Gorp, Patrick J. ; Busse, Rudi ; Brandes, Ralf P. / Xanthine oxidase inhibitor tungsten prevents the development of atherosclerosis in ApoE knockout mice fed a Western-type diet. In: Free Radical Biology and Medicine. 2006 ; Vol. 41, No. 9. pp. 1353-1360.
@article{032f5fa258b4430d9b56eac7af5511e1,
title = "Xanthine oxidase inhibitor tungsten prevents the development of atherosclerosis in ApoE knockout mice fed a Western-type diet",
abstract = "Hyperlipidemia enhances xanthine oxidase (XO) activity. XO is an important source of reactive oxygen species (ROS). Since ROS are thought to promote atherosclerosis, we hypothesized that XO is involved in the development of atherosclerosis. ApoE -/- mice were fed a Western-type (WD) or control diet. In subgroups, tungsten (700 mg/L) was administered to inhibit XO. XO is a secreted enzyme which is formed in the liver as xanthine dehydrogenase (XDH) and binds to the vascular endothelium. High expression of XDH was found in the liver and WD increased liver XDH mRNA and XDH protein expression. WD induced the conversion of XDH to the radical-forming XO. Moreover, WD increased the hepatic expression of CD40, demonstrating activation of hepatic cells. Aortic tissue of ApoE -/- mice fed a WD for 6 months exhibited marked atherosclerosis, attenuated endothelium-dependent relaxation to acetylcholine, increased vascular oxidative stress, and mRNA expression of the chemokine KC. Tungsten treatment had no effect on plasma lipids but lowered the plasma XO activity. In animals fed a control diet, tungsten had no effect on radical formation, endothelial function, or atherosclerosis development. In mice fed a WD, however tungsten attenuated the vascular superoxide anion formation, prevented endothelial dysfunction, and attenuated KC mRNA expression. Most importantly, tungsten treatment largely prevented the development of atherosclerosis in the aorta of ApoE -/- mice on WD. Therefore, tungsten, potentially via the inhibition of XO, prevents the development of endothelial dysfunction and atherosclerosis in ApoE -/- mice on WD.",
keywords = "Atherosclerosis, Oxidative stress",
author = "Katrin Schr{\"o}der and Carmine Vecchione and Oliver Jung and Schreiber, {Judith G.} and Ronit Shiri-Sverdlov and {van Gorp}, {Patrick J.} and Rudi Busse and Brandes, {Ralf P.}",
year = "2006",
month = "11",
day = "1",
doi = "10.1016/j.freeradbiomed.2006.03.026",
language = "English",
volume = "41",
pages = "1353--1360",
journal = "Free Radical Biology and Medicine",
issn = "0891-5849",
publisher = "Elsevier Inc.",
number = "9",

}

TY - JOUR

T1 - Xanthine oxidase inhibitor tungsten prevents the development of atherosclerosis in ApoE knockout mice fed a Western-type diet

AU - Schröder, Katrin

AU - Vecchione, Carmine

AU - Jung, Oliver

AU - Schreiber, Judith G.

AU - Shiri-Sverdlov, Ronit

AU - van Gorp, Patrick J.

AU - Busse, Rudi

AU - Brandes, Ralf P.

PY - 2006/11/1

Y1 - 2006/11/1

N2 - Hyperlipidemia enhances xanthine oxidase (XO) activity. XO is an important source of reactive oxygen species (ROS). Since ROS are thought to promote atherosclerosis, we hypothesized that XO is involved in the development of atherosclerosis. ApoE -/- mice were fed a Western-type (WD) or control diet. In subgroups, tungsten (700 mg/L) was administered to inhibit XO. XO is a secreted enzyme which is formed in the liver as xanthine dehydrogenase (XDH) and binds to the vascular endothelium. High expression of XDH was found in the liver and WD increased liver XDH mRNA and XDH protein expression. WD induced the conversion of XDH to the radical-forming XO. Moreover, WD increased the hepatic expression of CD40, demonstrating activation of hepatic cells. Aortic tissue of ApoE -/- mice fed a WD for 6 months exhibited marked atherosclerosis, attenuated endothelium-dependent relaxation to acetylcholine, increased vascular oxidative stress, and mRNA expression of the chemokine KC. Tungsten treatment had no effect on plasma lipids but lowered the plasma XO activity. In animals fed a control diet, tungsten had no effect on radical formation, endothelial function, or atherosclerosis development. In mice fed a WD, however tungsten attenuated the vascular superoxide anion formation, prevented endothelial dysfunction, and attenuated KC mRNA expression. Most importantly, tungsten treatment largely prevented the development of atherosclerosis in the aorta of ApoE -/- mice on WD. Therefore, tungsten, potentially via the inhibition of XO, prevents the development of endothelial dysfunction and atherosclerosis in ApoE -/- mice on WD.

AB - Hyperlipidemia enhances xanthine oxidase (XO) activity. XO is an important source of reactive oxygen species (ROS). Since ROS are thought to promote atherosclerosis, we hypothesized that XO is involved in the development of atherosclerosis. ApoE -/- mice were fed a Western-type (WD) or control diet. In subgroups, tungsten (700 mg/L) was administered to inhibit XO. XO is a secreted enzyme which is formed in the liver as xanthine dehydrogenase (XDH) and binds to the vascular endothelium. High expression of XDH was found in the liver and WD increased liver XDH mRNA and XDH protein expression. WD induced the conversion of XDH to the radical-forming XO. Moreover, WD increased the hepatic expression of CD40, demonstrating activation of hepatic cells. Aortic tissue of ApoE -/- mice fed a WD for 6 months exhibited marked atherosclerosis, attenuated endothelium-dependent relaxation to acetylcholine, increased vascular oxidative stress, and mRNA expression of the chemokine KC. Tungsten treatment had no effect on plasma lipids but lowered the plasma XO activity. In animals fed a control diet, tungsten had no effect on radical formation, endothelial function, or atherosclerosis development. In mice fed a WD, however tungsten attenuated the vascular superoxide anion formation, prevented endothelial dysfunction, and attenuated KC mRNA expression. Most importantly, tungsten treatment largely prevented the development of atherosclerosis in the aorta of ApoE -/- mice on WD. Therefore, tungsten, potentially via the inhibition of XO, prevents the development of endothelial dysfunction and atherosclerosis in ApoE -/- mice on WD.

KW - Atherosclerosis

KW - Oxidative stress

UR - http://www.scopus.com/inward/record.url?scp=33749235510&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33749235510&partnerID=8YFLogxK

U2 - 10.1016/j.freeradbiomed.2006.03.026

DO - 10.1016/j.freeradbiomed.2006.03.026

M3 - Article

C2 - 17023262

AN - SCOPUS:33749235510

VL - 41

SP - 1353

EP - 1360

JO - Free Radical Biology and Medicine

JF - Free Radical Biology and Medicine

SN - 0891-5849

IS - 9

ER -